Quick Answer
Lexaria Bioscience Corp. reported Total Revenue of $705.9 thousand for fiscal year 2025.
Lexaria Bioscience Corp. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $705.9K | +52.0% |
| 2024 | $464.3K | +105.2% |
| 2023 | $226.2K | -11.4% |
| 2022 | $255.4K | -64.7% |
| 2021 | $722.7K | +129.6% |
| 2020 | $314.8K | +41.4% |
| 2019 | $222.6K | -48.6% |
| 2018 | $433.3K | +580.9% |
| 2017 | $63.6K | +56.3% |
| 2016 | $40.7K | +177.0% |
| 2015 | $14.7K | — |
| 2014 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $0.00 | -100.0% | -100.0% |
| May 31, 2025 | $174.0K | +107.1% | +0.0% |
| February 28, 2025 | $174.0K | +20.0% | -5.4% |
| November 30, 2024 | $183.9K | +21.6% | +119.0% |
| May 31, 2024 | $84.0K | +8.1% | -42.1% |
| February 29, 2024 | $145.0K | +624.1% | -4.1% |
| November 30, 2023 | $151.3K | +54.8% | +94.7% |
| May 31, 2023 | $77.7K | -22.1% | +288.0% |
- Lexaria Bioscience Corp. showed an increase of +52.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: